KRAS and lung adenocarcinoma: The TMA slides, obtained from the University of Pittsburgh Lung Specialized Program of Research Excellence (SPORE) (Villaruz et al., 2016) and constructed using randomly selected archival lung adenocarcinomas with known EGFR and KRAS mutation status, were stained for MAP4K4.